Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 2 Open-label Study of Loncastuximab Tesirine in Combination with Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Patients with Diffuse Large B-cell Lymphoma (DLBCL) (LOTIS-9)
$188.6K Funding
5 People
External
Related Topics
lymphoma,
cancer treatment,
immunotherapy,
clinical trial,
drug combination
People
Lora Inclan
(CD)
Cancer Center Division
﹒Clinical Research Coordinator III
Sandra Ortega
(CD)
Cancer Center Division
﹒Clinical Research Coordinator II
Brianna Denton
(CD)
Cancer Center Division
﹒Research Compliance Manager I
Abhijeet Kumar
Principal Investigator (PI)
Medicine
﹒Associate Professor, Medicine - (Clinical Scholar Track)
Carolyn Lane
(CD)
Cancer Center Division
﹒Research Laboratory Manager I
